The company has a strong cash position of $471m, despite a net loss of $63m in 2024, providing a long funding runway. Click ...

"FDA approves Neurelis’ nasal spray for seizures" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has b ...

The experts recommend 24-hour or “second-generation” antihistamines like cetirizine (Zyrtec) or fexofenadine (Allegra), which ...

Researchers have developed and preliminarily tested a composite score that simultaneously assesses the severity of asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) in patients with both ...

Ablation of the posterior nasal nerve leads to durable reductions in symptoms of chronic rhinitis, new research shows.

Sanofi today shared new progress from its mid- to late-stage respiratory pipeline, including preliminary phase 2 results for amlitelimab in adults with moderate-to-severe asthma.

Learn the essential facts about fungal sinus infections, from recognizing early warning signs to understanding treatment ...

"The polyps had eroded so much the bone around the perimeter of the sinuses that they were entering into the brain cavity and ...

Bucks County specialty pharmaceutical company Optinose first started exploring mergers and licensing deals in early 2022.

Tezepelumab was linked to significantly reduced nasal polyp size and nasal congestion vs placebo in adults with severe CRSwNP.